Jane Street’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-73,118
| Closed | -$3.88M | – | 10319 |
|
|
2025
Q1 | $4.46M | Buy |
+73,118
| New | +$6.23M | ﹤0.01% | 3097 |
|
|
2024
Q4 | – | Sell |
-6,122
| Closed | -$720K | – | 10044 |
|
|
2024
Q3 | $788K | Buy |
+6,122
| New | +$799K | ﹤0.01% | 6344 |
|
|
2024
Q1 | – | Sell |
-81,349
| Closed | -$9.92M | – | 9684 |
|
|
2023
Q4 | $9.92M | Buy |
81,349
+80,572
| +10,370% | +$6.16M | ﹤0.01% | 1970 |
|
|
2023
Q3 | $59.2K | Sell |
777
-352
| -31% | -$36.1K | ﹤0.01% | 8115 |
|
|
2023
Q2 | $134K | Sell |
1,129
-2,195
| -66% | -$274K | ﹤0.01% | 7869 |
|
|
2023
Q1 | $326K | Sell |
3,324
-32,935
| -91% | -$4.47M | ﹤0.01% | 7053 |
|
|
2022
Q4 | $5.13M | Buy |
36,259
+35,588
| +5,304% | +$4.96M | ﹤0.01% | 2438 |
|
|
2022
Q3 | $94K | Buy |
671
+53
| +9% | +$9.71K | ﹤0.01% | 8676 |
|
|
2022
Q2 | $83K | Sell |
618
-13,860
| -96% | -$2.36M | ﹤0.01% | 8740 |
|
|
2022
Q1 | $4.54M | Buy |
14,478
+14,141
| +4,196% | +$5.33M | ﹤0.01% | 3187 |
|
|
2021
Q4 | $242K | Buy |
337
+119
| +55% | +$114K | ﹤0.01% | 8534 |
|
|
2021
Q3 | $241K | Sell |
218
-2,212
| -91% | -$2.72M | ﹤0.01% | 8576 |
|
|
2021
Q2 | $3.58M | Sell |
2,430
-3,202
| -57% | -$4.44M | ﹤0.01% | 3240 |
|
|
2021
Q1 | $8.89M | Buy |
+5,632
| New | +$13.2M | ﹤0.01% | 1675 |
|
|
2020
Q4 | – | Sell |
-257
| Closed | -$410K | – | 7821 |
|
|
2020
Q3 | $275K | Sell |
257
-2,489
| -91% | -$2.85M | ﹤0.01% | 6010 |
|
|
2020
Q2 | $3.26M | Sell |
2,746
-2,617
| -49% | -$2.27M | ﹤0.01% | 2388 |
|
|
2020
Q1 | $2.42M | Buy |
5,363
+4,766
| +798% | +$4.34M | ﹤0.01% | 1828 |
|
|
2019
Q4 | $687K | Buy |
+597
| New | +$536K | ﹤0.01% | 3278 |
|
|
2019
Q3 | – | Sell |
-5,731
| Closed | -$4.76M | – | 5458 |
|
|
2019
Q2 | $5.75M | Buy |
5,731
+1,600
| +39% | +$1.55M | 0.01% | 959 |
|
|
2019
Q1 | $4.95M | Buy |
4,131
+3,063
| +287% | +$3.19M | 0.01% | 1154 |
|
|
2018
Q4 | $702K | Buy |
1,068
+206
| +24% | +$216K | ﹤0.01% | 3038 |
|
|
2018
Q3 | $1.6M | Buy |
+862
| New | +$1.69M | ﹤0.01% | 2146 |
|
|
2018
Q1 | – | Sell |
-1,515
| Closed | -$2.82M | – | 5140 |
|
|
2017
Q4 | $2.36M | Sell |
1,515
-4,096
| -73% | -$6.27M | 0.01% | 1443 |
|
|
2017
Q3 | $9.59M | Buy |
5,611
+4,775
| +571% | +$6.63M | 0.03% | 536 |
|
|
2017
Q2 | $1.05M | Sell |
836
-613
| -42% | -$618K | ﹤0.01% | 2147 |
|
|
2017
Q1 | $1.38M | Buy |
1,449
+995
| +219% | +$887K | 0.01% | 1708 |
|
|
2016
Q4 | $284K | Sell |
454
-296
| -39% | -$222K | ﹤0.01% | 3409 |
|
|
2016
Q3 | $731K | Sell |
750
-8,654
| -92% | -$7.14M | ﹤0.01% | 2333 |
|
|
2016
Q2 | $5.31M | Buy |
9,404
+8,239
| +707% | +$5.16M | 0.03% | 599 |
|
|
2016
Q1 | $639K | Sell |
1,165
-94
| -7% | -$59.5K | ﹤0.01% | 2326 |
|
|
2015
Q4 | $2.13M | Buy |
1,259
+745
| +145% | +$1.21M | 0.01% | 1012 |
|
|
2015
Q3 | $668K | Buy |
+514
| New | +$1.57M | ﹤0.01% | 2004 |
|
Other funds holding LABU
JF
TRCT
XT
HF
MIG
TSS
Jane Street's LABU Position: Q2 2025 in Review
Jane Street sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q2 2025, closing a stake of 73,118 shares — an estimated $3.88M sold.
Jane Street first reported a position in LABU in Q3 2015 and held it in 32 quarters. The position peaked at $9.92M in Q4 2023. 33 funds tracked by Wall St. Rank hold LABU as of Q2 2025.
- Jane Street reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q2 2025 after selling out during the quarter.
- Jane Street sold 73,118 Direxion Daily S&P Biotech Bull 3X ETF shares in Q2 2025, an estimated $3.88M.
- Jane Street first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q3 2015 and held it in 32 quarters.
- Jane Street's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $9.92M in Q4 2023.
- 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q2 2025.
Based on Jane Street's 13F filing for Q2 2025, filed 14 Aug 2025.